Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone 20 mg versus 40 mg intra-articular injection for mild rotator cuff injury
IRCT20130812014333N187Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of methylprednisolone in rotator cuff tendinitis (3 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Shoulder function, Pain intensity and 1 more. Started Jul 2022; status: completed.
02
Drugs
methylprednisolone
03
Conditions
rotator cuff tendinitis
Beyond the preview
Go deeper on IRCT20130812014333N187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N187.